Results 281 to 290 of about 1,109,187 (337)

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data

Clinical Pharmacology &Therapeutics, EarlyView.
Hypertension is a known modifiable risk factor for Alzheimer’s disease and related dementia (ADRD). However, it is unknown how variance in hypertension control, antihypertensive medications, and social determinants of health, such as social deprivation index (SDI), influence the risk of developing ADRD.
Eissa A. Jafari, Mona Alshahawey, Muhammad A. Zaman, Steven M. Smith, Yan Gong, Glenn E. Smith, Caitrin W. McDonough   +6 more
wiley   +1 more source

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

Tooth Loss and Cardiovascular Risk Burden in Myocardial Infarction Patients. [PDF]

J Clin Med
Cinezan C, Rus CB, Cinezan A, Vaida LL.
europepmc   +1 more source

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV: An Emerging Frontier for Clinical Pharmacology

Clinical Pharmacology &Therapeutics, EarlyView.
As antiretroviral therapy (ART) prolongs lifespans, people with HIV (PWH) face a new syndemic: Cardiovascular‐Kidney‐Metabolic (CKM) syndrome. Yet CKM in PWH is poorly characterized. Inflammation, complex pharmacokinetic (PK) alterations, ART‐associated metabolic effects, and gut dysbiosis amplify risk. Managing CKM increases medication burden, thereby
Aaron S. Devanathan, Thomas D. Nolin
wiley   +1 more source

Genetic Scale for Predicting the No-Reflow Phenomenon in Myocardial Infarction. [PDF]

Sovrem Tekhnologii Med
Pochinka IG, Frolov AA, Kuzmichev KV, Shchelchkova NA, Pershin VI, Maximova NS, Budkina ML, Predeina IV, Frolov IA, Kashtanov MG.   +9 more
europepmc   +1 more source

Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction. [PDF]

Nat Commun
Clemente-Moragón A, Suárez-Barrientos A, Gómez Tech M, López-Palomar Tech LP, Callejas Alejano S, Martínez F, Fernández FJ, Vega MC, Tech AP, Dopazo A, Sánchez-Cabo F, Fuster V, Oliver E, Ibáñez B.   +13 more
europepmc   +1 more source

Clinical Efficacy of Periosteum‐Preserving Iliac Crest Transverse Transport for Symptomatic High‐Level Lower Extremity Arteriosclerosis Obliterans

Chronic Diseases and Translational Medicine, EarlyView.
Guangchen Nie, Xiangyue Meng, Yong Liu, Xuguang Hao, Yang Liu, Shouyang Xiang, Yongxin Huo, Long Jiang, Qiang Xu, Yicun Lu   +9 more
wiley   +1 more source

Macrophage polarization in acute myocardial infarction: multidimensional regulation and emerging therapeutic opportunities. [PDF]

Front Immunol
Ye Z, Wang B, Wan Z, Guo J.
europepmc   +1 more source